THE INCIDENCE OF SCINTIGRAPHICALLY VIABLE AND NONVIABLE TISSUE BY RB-82 AND FLUORINE-18-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHIC IMAGING IN PATIENTS WITH PRIOR INFARCTION AND LEFT-VENTRICULAR DYSFUNCTION
Rt. Go et al., THE INCIDENCE OF SCINTIGRAPHICALLY VIABLE AND NONVIABLE TISSUE BY RB-82 AND FLUORINE-18-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHIC IMAGING IN PATIENTS WITH PRIOR INFARCTION AND LEFT-VENTRICULAR DYSFUNCTION, Journal of nuclear cardiology, 3(2), 1996, pp. 96-104
Citations number
25
Categorie Soggetti
Cardiac & Cardiovascular System","Radiology,Nuclear Medicine & Medical Imaging
Background. Although reversible perfusion defects, perfusion-metabolis
m mismatch and match patterns are important for differentiating viable
from nonviable myocardium, the frequency of these scintigraphic patte
rns has not been reported. The study objective was to establish the in
cidence of these scintigraphic patterns to estimate the clinical need
for metabolic positron emission tomography for evaluating tissue viabi
lity in patients with prior myocardial infarction (MI). Methods and Re
sults. Rb-82 perfusion images were interpreted to identify reversible
or irreversible defects, followed by determination of their F-18-fluor
odeoxyglucose (F-18-FDG) uptake pattern. In 155 patients with prior MI
, analysis of 613 abnormal segments showed reversible perfusion defect
s in 13%. The 87% irreversible defects, 18% showed perfusion-metabolis
m mismatch, whereas 69% showed the match pattern. Reversible perfusion
defects and perfusion-metabolism mismatches were noted in 20% (31/155
) and 29% (45/155) of patients, respectively, whereas the match patter
n was noted in 51% (79/155) of patients. Conclusion. Irreversible perf
usion defects were common in our patients with prior MI, and distincti
on between viable and nonviable tissue was not possible by perfusion i
maging alone. The identification of hibernating myocardium was possibl
e only with the additional F-18-FDG imaging in about one third of pati
ents. This indicates a significant clinical demand for F-18-FDG imagin
g that identifies patients who will benefit from revascularization.